Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Not yet recruiting 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Neoplasms 2Motor Activity 2Thrombocythemia, Essential 1Rehabilitation Exercise 1Primary Myelofibrosis 1Polycythemia Vera 1Overweight 1Obesity 1Myeloproliferative Disorders 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Brain Neoplasms 1

Interventions

Androgen Antagonists 10darolutamide 6Magnetic Resonance Spectroscopy 6apalutamide 5Docetaxel 5enzalutamide 4Specimen Handling 4Radiotherapy 4Radiosurgery 4Abiraterone Acetate 4Electroacupuncture 3Brachytherapy 3pembrolizumab 2bicalutamide 2Standard of Care 2Resistance Training 2Radiation 2Prednisone 2Pluvicto 2Interviews as Topic 2Gonadotropin-Releasing Hormone 2Glutamate Carboxypeptidase II 2Bone Density 2Absorptiometry, Photon 2testosterone 17 beta-cypionate 1relugolix 1perflutren 1olaparib 1luprolide acetate gel depot 1fluciclovine F-18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × Resistance Training × Clear all
NCT06828003 2025-02-14

Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer

University of Toronto

Phase NA Not yet recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06271551 2024-02-21

ESTRACISE

Central Finland Hospital District

Phase 2 Not yet recruiting
310 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡